CoChat

m6A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability

Open access

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

N 6-methyladenosine (m 6 A) has been identified to exert critical roles in human cancer; however, the regulation of m 6 A modification on glioblastoma multiforme (GBM) and long non-coding RNA (lncRNA) CASC9 (cancer susceptibility 9) is still unclear. Firstly, MeRIP-Seq revealed the m 6 A profile in the GBM. Moreover, the m 6 A-related lncRNA CASC9 expression was significantly elevated in the GBM tissue and its ectopic high expression was associated with poor survival, acting as an independent prognostic factor for GBM patients. Functionally, the aerobic glycolysis was promoted in the CASC9 overexpression transfection, which was inhibited in CASC9 knockdown in GBM cells. Mechanistically, m 6 A reader IGF2BP2 (insulin-like growth factor 2 mRNA binding protein 2) could recognize the m 6 A site of CASC9 and enhance its stability, then CASC9 cooperated with IGF2BP2, forming an IGF2BP2/CASC9 complex, to increase the HK2 (Hexokinase 2) mRNA stability. Our findings reveal that CASC9/IGF2BP2/HK2 axis promotes the aerobic glycolysis of GBM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41420-021-00674-y

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 MeRIP-Seq revealed the m6A profile in the GBM. A MeRIP-Seq was performed and found that the m6A peaks frequency was mainly located in the 5-end untranslated regions (5ʹ-UTR), coding region (CDS) and 3ʹ-UTR. B Pie chart demonstrated the distribution of m6A peaks in the GBM genome. C Volcano plot displayed the upregulated or downregulated targets labeled with m6A peaks. D The m6A motif with the highest frequency is the GGACU motif.
Fig. 1 MeRIP-Seq revealed the m6A profile in the GBM. A MeRIP-Seq was performed and found that the m6A peaks frequency was mainly located in the 5-end untranslated regions (5ʹ-UTR), coding region (CDS) and 3ʹ-UTR. B Pie chart demonstrated the distribution of m6A peaks in the GBM genome. C Volcano plot displayed the upregulated or downregulated targets labeled with m6A peaks. D The m6A motif with the highest frequency is the GGACU motif.CC BY · PubMed Central
Fig. 2 m6A modified lncRNA CASC9 indicated the unfavorable prognosis of GBM. A Several m6A modified lncRNAs were screened by MeRIP-Seq. The m6A modified sites in the RRACH motif were shown using IGV (Integrative Genomics Viewer). B In the clinically collected GBM tissue specimens, CASC9 expression was detected using RT-PCR as compared to the adjacent normal tissue. C On the basis of median value, the clinical tissue specimens were divided into high expression group and low expression group. D Overall survival (OS) curve calculated by the Kaplan−Meier method for GBM patients. Data are presented as the mean ± SD. **P < 0.01.
Fig. 2 m6A modified lncRNA CASC9 indicated the unfavorable prognosis of GBM. A Several m6A modified lncRNAs were screened by MeRIP-Seq. The m6A modified sites in the RRACH motif were shown using IGV (Integrative Genomics Viewer). B In the clinically collected GBM tissue specimens, CASC9 expression was detected using RT-PCR as compared to the adjacent normal tissue. C On the basis of median value, the clinical tissue specimens were divided into high expression group and low expression group. D Overall survival (OS) curve calculated by the Kaplan−Meier method for GBM patients. Data are presented as the mean ± SD. **P < 0.01.CC BY · PubMed Central
Fig. 3 m6A reader IGF2BP2 enhanced the stability of lncRNA CASC9. A In the GBM cohort, IGF2BP2 was found to be upregulated according to the GEPIA dataset (http://gepia.cancer-pku.cn/index). B Western blot analysis found the IGF2BP2 expression in U87MG cells with IGF2BP2 overexpression by plasmids transfection. C RNA stability assay demonstrated the remaining lncRNA CASC9 in U87MG cells when treated with Act D. D MeRIP-Seq data by IGV showed the two m6A modification sites in the 3ʹ-UTR of CASC9. E The location of m6A modification sites in the CASC9 gene. F MeRIP-qPCR demonstrated the CASC9 expression in GBM cell lines (U87MG) using anti-m6A antibody. G RIP-qPCR showed the interaction within CASC9 and IGF2BP2 in U87MG cells using anti-IGF2BP2 antibody. Data are presented as the mean ± SD. **P < 0.01.
Fig. 3 m6A reader IGF2BP2 enhanced the stability of lncRNA CASC9. A In the GBM cohort, IGF2BP2 was found to be upregulated according to the GEPIA dataset (http://gepia.cancer-pku.cn/index). B Western blot analysis found the IGF2BP2 expression in U87MG cells with IGF2BP2 overexpression by plasmids transfection. C RNA stability assay demonstrated the remaining lncRNA CASC9 in U87MG cells when treated with Act D. D MeRIP-Seq data by IGV showed the two m6A modification sites in the 3ʹ-UTR of CASC9. E The location of m6A modification sites in the CASC9 gene. F MeRIP-qPCR demonstrated the CASC9 expression in GBM cell lines (U87MG) using anti-m6A antibody. G RIP-qPCR showed the interaction within CASC9 and IGF2BP2 in U87MG cells using anti-IGF2BP2 antibody. Data are presented as the mean ± SD. **P < 0.01.CC BY · PubMed Central
Fig. 4 LncRNA CASC9 accelerated the aerobic glycolysis of GBM. A RT-PCR unveiled the CASC9 expression in human glioblastoma cell lines (U87MG, U251) relative to normal human astrocytes (NHA). B ShRNA-expressing lentiviruses targeting CASC9 were transfected into U87MG cells. CASC9 overexpression plasmids were transfected into U251 cells. RT-PCR unveiled the CASC9 expression relative to the control group. C Glucose uptake analysis, D lactate production and E ATP generation analysis were performed in U251 cells and U87MG cells to control group (vector or shRNA). F Extracellular acidification rate (ECAR) analysis was performed for the glycolysis stress test in U251 cells and U87MG cells. G Oxygen consumption rate (OCR) assay was performed for the respiratory rate in U251 cells and U87MG cells. Data are presented as the mean ± SD. **P < 0.01, *P < 0.05.
Fig. 4 LncRNA CASC9 accelerated the aerobic glycolysis of GBM. A RT-PCR unveiled the CASC9 expression in human glioblastoma cell lines (U87MG, U251) relative to normal human astrocytes (NHA). B ShRNA-expressing lentiviruses targeting CASC9 were transfected into U87MG cells. CASC9 overexpression plasmids were transfected into U251 cells. RT-PCR unveiled the CASC9 expression relative to the control group. C Glucose uptake analysis, D lactate production and E ATP generation analysis were performed in U251 cells and U87MG cells to control group (vector or shRNA). F Extracellular acidification rate (ECAR) analysis was performed for the glycolysis stress test in U251 cells and U87MG cells. G Oxygen consumption rate (OCR) assay was performed for the respiratory rate in U251 cells and U87MG cells. Data are presented as the mean ± SD. **P < 0.01, *P < 0.05.CC BY · PubMed Central
Fig. 5 CASC9/IGF2BP2 complex contributed to the stability of HK2 mRNA. A The correlation analysis within the expression of IGF2BP2 and HK2 in the GBM group, which was based on ATGC (http://gepia.cancer-pku.cn/). B MeRIP-Seq indicated that there was a remarkable m6A site in the 3ʹ-UTR of HK2 mRNA. C The m6A site in the 3ʹ-UTR of HK2 mRNA was AGGGACU. D In U251 cells, RT-PCR assay detected the HK2 mRNA levels when transfected with IGF2BP2 overexpression. In U87MG cells, RT-PCR assay detected the HK2 mRNA levels when transfected with CASC9 overexpression. E MeRIP-PCR assay illustrated the HK2 mRNA expression using anti-m6A antibody as compared to Input in U87MG. F RIP-qPCR unveiled the HK2 mRNA level in U251 cells or U87MG cells using IGF2BP2 antibody. G RNA stability assay demonstrated the HK2 mRNA in U251 cells or in U87MG cells when treated with Act D. Data are presented as the mean ± SD. **P < 0.01.
Fig. 5 CASC9/IGF2BP2 complex contributed to the stability of HK2 mRNA. A The correlation analysis within the expression of IGF2BP2 and HK2 in the GBM group, which was based on ATGC (http://gepia.cancer-pku.cn/). B MeRIP-Seq indicated that there was a remarkable m6A site in the 3ʹ-UTR of HK2 mRNA. C The m6A site in the 3ʹ-UTR of HK2 mRNA was AGGGACU. D In U251 cells, RT-PCR assay detected the HK2 mRNA levels when transfected with IGF2BP2 overexpression. In U87MG cells, RT-PCR assay detected the HK2 mRNA levels when transfected with CASC9 overexpression. E MeRIP-PCR assay illustrated the HK2 mRNA expression using anti-m6A antibody as compared to Input in U87MG. F RIP-qPCR unveiled the HK2 mRNA level in U251 cells or U87MG cells using IGF2BP2 antibody. G RNA stability assay demonstrated the HK2 mRNA in U251 cells or in U87MG cells when treated with Act D. Data are presented as the mean ± SD. **P < 0.01.CC BY · PubMed Central
Fig. 6 Schematic diagram of CASC9 on the GBM aerobic glycolysis through IGF2BP2/HK2 pathway.
Fig. 6 Schematic diagram of CASC9 on the GBM aerobic glycolysis through IGF2BP2/HK2 pathway.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 21 references

Cited by

See all 64

Metadata

Authors
Liu, H., Qin, S., Liu, C., Jiang, L., Li, C., Yang, J., Zhang, S., Yan, Z., Liu, X., Yang, J., & Sun, X.
Affiliations
  • Second Hospital of Hebei Medical University (CN)
  • Hebei Medical University (CN)
Corresponding author
Sun, Xiaofeng
Venue
Cell Death Discovery
Published
2021-10-13
Volume
7
Issue
1
Pages
292-292
ISSN
2058-7716 (ISSN-L)
OpenAlex
W3205577640
Cited by
58
References
21
Citations by year
2026: 10 · 2025: 10 · 2024: 17 · 2023: 10 · 2022: 11
FWCI
3.45
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death Discovery (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • China Aerospace Science and Technology Corporation
  • Fondo para la Investigación Científica y Tecnológica (QN2018020)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
glioblastoma, N6-methyladenosine, m6A reader, IGF2BP2, CASC9, long non-coding RNA, HK2, aerobic glycolysis, mRNA stability, prognostic factors, cancer metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: m6A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability. https://app.cochat.ai/papers/10.1038/s41420-021-00674-y
The paper
Liu, H., Qin, S., Liu, C., Jiang, L., Li, C., Yang, J., Zhang, S., Yan, Z., Liu, X., Yang, J., & Sun, X. (2021). m6A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability. Cell Death Discovery. https://doi.org/10.1038/s41420-021-00674-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.